COPD: Will There Be Room for Nebulisers After the Current COVID-19 Pandemic?
| Main Authors: | António Duarte de Araújo, Jaime Correia-de-Sousa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-10-01
|
| Series: | Open Respiratory Archives |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2659663620300655 |
Similar Items
-
Decalogue of nebulisation
by: Adam J. Sybilski
Published: (2019-07-01) -
Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19
by: Waiting Tai, et al.
Published: (2021-08-01) -
Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPD
by: Phillip D. Monk, et al.
Published: (2024-05-01) -
Contamination and current practice in decontamination pof nebulisers in ventilated patients
by: A. Ellis, et al.
Published: (2013-01-01) -
Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence
by: Frank M. P. van Haren, et al.
Published: (2020-07-01)